Hormone treatment of gender identity disorder in a cohort of children and adolescents

In reply: We thank Hyde and Conway and colleagues for their correspondence following our report on treatment for young people with gender identity disorder (GID).1 We follow current international consensus recommendations for management,2,3 but accept that as more research is performed, there may be future adjustments to endorsed protocols. At present, patients can apply to the Family Court of Australia for authorisation of treatment that varies from current guidelines, such as commencement of cross-sex hormone therapy before the age of 16 years.1